Clinical course of SARS-CoV-2 infection and recovery in lung transplant recipients.
Anil J TrindadeKaitlyn C ChapinWhitney D GannonHaley HoyCaitlin T DemarestEric S LambrightKatie A McPhersonStephanie G NorfolkIvan M RobbinsMatthew D BacchettaDavid Brett ErasmusCiara M ShaverPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
This study describes the natural history of SARS-CoV-2 infection in a large cohort of lung transplant recipients. Although one third of patients develop ALAD requiring augmented immunosuppression, infection with SARS-CoV-2 is not associated with worsening lung function.